Mon4t Overview
Mon4t specializes in developing technology for the efficient and effective treatment of neurological disorders. The company has developed both a real-time remote brain monitor that is inexpensive, inclusive, and personalized to each patient and an app that enables neurological evaluations of motor and cognitive skills to be performed by anyone at any time. Mon4ts market includes physicians, who use the clinic version and pay per test; and patients, who use the home version and pay per month. The technology can also be integrated through a SaaS solution into products designed for the pharmaceutical industry, medical device manufacturers, and HMOs. In use worldwide, the companys technology is FDA and CE cleared, with thousands of samples from a wide range of disorders.
Cumulative Funding Raised Over Time ($)
Latest News
growth-positive
Mon4t Sets up a US Subsidiary
Montfort Brain Monitor (Mon4t), an Israeli medical company, has announced the opening of its US-based operations in New York City. Mon4t provides remote neurological evaluation using smartphone technology and AI. The companys FDA-approved solution allows for remote monitoring and tests for patients with neurological disorders. With the expansion into the US, Mon4t aims to work more closely with existing and new North American customers. The company is hiring a US Chief Business Officer and additional marketing and sales employees. The tele-neurology market potential in the US alone is estimated to be over $50 billion. Montfort Brain Monitor has experienced growing demand, particularly in the US, due to the limitations on clinical visits caused by the COVID-19 pandemic.
CustomersExpand
growth-positive
A smartphone technology to diagnose psychiatric diseases
Israeli medical startup Montfort has launched its Brain Profiler, a science-based method that aims to accurately diagnose mental disorders as brain disturbances. Developed by psychiatrist Dr. Abraham Peled, the approach combines classical psychiatry with computational neuroscience. Montfort already uses smartphone technology and AI to provide digital neurological tests for patients with conditions like Parkinsons disease. The company has expanded its test protocol to include indicators for anxiety, depression, and more. The Brain Profiler will also be used by Israeli astronaut Eytan Stibbe on his journey to the International Space Station in 2022. The app will be used for motor and cognitive self-tests, with physicians on Earth monitoring the astronauts functioning in real time.
CustomersPartners
growth-positive
Israeli startup Mon4t paving the way for mental health digital revolution
Israeli medical device startup Mon4t has developed an app that helps physicians monitor and diagnose patients psychiatric symptoms in real-time. The app, called Mon4t, allows physicians to monitor a patients motor, cognitive, psychiatric, and medical history conditions on any smartphone. Mon4t recently raised an undisclosed sum in a seed round from private investors, Next Leap Ventures, and the Israel Innovation Authority. The company has received FDA approval and is working on collaborations with medical device and pharmaceutical companies, including Medtronic. The app aims to address the complex nature of mental health disorders and provide a more holistic approach to diagnosis and treatment. Mon4t sees telehealth and telepsychiatry as growing markets, especially in the COVID-19 era.
InvestmentPartners
growth-positive
Israeli Strartup Montfort transforms Mental Health into an Exact Science
Montfort, an innovative medical startup specializing in neurological disorders, has announced a new platform to help diagnose and treat psychiatric disorders. The platform is based on the Brain Profiler, a science-based method that diagnoses mental disorders as brain disturbances. The company uses smartphone technology and AI to provide FDA-cleared digital neurological tests for patients with conditions such as Parkinson’s disease and Huntington’s disease. The new platform will allow for the self-collection of patient indicators and the analysis of data in the cloud. The goal is to build a large database for validation of computational neuroscience-based brain diagnosis. The company aims to bridge the gap between classical Psychiatry and computational neuroscience.
CustomersPartners
growth-positive
Monitoring brain disorders from home with your phone
Israeli startup Montfort has developed an FDA-approved app called EncephaLog that allows patients with neurological disorders to be monitored remotely in real time. The app uses sensors built into smartphones to conduct digital neurological tests for conditions such as Parkinsons disease, Huntingtons disease, psychiatric disorders, and post-Covid-19 neurological symptoms. Montforts approach offers a superior alternative to in-person checkups and provides a platform for sampling patients during regular activity. The company is experiencing growth in demand for remote monitoring due to the Covid-19 pandemic, and many countries are starting to reimburse remote monitoring costs. Montfort is currently raising a Series A round to expand its operations.
CustomersInvestmentExpand
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $75K |
| Last funding | Undisclosed |
| Stage | Mature |
| Rounds | 3 |
| Investors | 2 |
Team Members
2
Employees: 1-10
Web & Social Links
| Website | mon4t.com |
| Careers | Careers page |
| App Store | App Store |
| Google Play | Google Play |
Locations
HaTahana 60, Binyamina, Israel
New York, NY, USA
Photos & Videos
3 item(s)
